These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22982899)

  • 1. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
    Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endometrial stromal sarcoma: morphologic features and detection of JAZF1-SUZ12 and YWHAE FAM22 fusion genes].
    Chang B; Lu LX; Tu XY; Cheng YF; Bi R; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):308-13. PubMed ID: 27142911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
    Lee CH; Mariño-Enriquez A; Ou W; Zhu M; Ali RH; Chiang S; Amant F; Gilks CB; van de Rijn M; Oliva E; Debiec-Rychter M; Dal Cin P; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 May; 36(5):641-53. PubMed ID: 22456610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.
    Kruse AJ; Croce S; Kruitwagen RF; Riedl RG; Slangen BF; Van Gorp T; Van de Vijver KK
    Int J Gynecol Cancer; 2014 Nov; 24(9):1616-22. PubMed ID: 25244606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
    Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
    Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
    Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
    Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas.
    Subbaraya S; Murthy SS; Devi G S
    Clin Pathol; 2020; 13():2632010X20916736. PubMed ID: 32524088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
    Sun L; Zhao W; Zhao Z; Zhu Y
    Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement.
    Lee CH; Hoang LN; Yip S; Reyes C; Marino-Enriquez A; Eilers G; Tao D; Chiang S; Fletcher JA; Soslow RA; Nucci MR; Oliva E
    Mod Pathol; 2014 May; 27(5):751-7. PubMed ID: 24186140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
    Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
    Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
    Lee CH; Ou WB; Mariño-Enriquez A; Zhu M; Mayeda M; Wang Y; Guo X; Brunner AL; Amant F; French CA; West RB; McAlpine JN; Gilks CB; Yaffe MB; Prentice LM; McPherson A; Jones SJ; Marra MA; Shah SP; van de Rijn M; Huntsman DG; Dal Cin P; Debiec-Rychter M; Nucci MR; Fletcher JA
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):929-34. PubMed ID: 22223660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
    Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of
    Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
    Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.
    Dewaele B; Przybyl J; Quattrone A; Finalet Ferreiro J; Vanspauwen V; Geerdens E; Gianfelici V; Kalender Z; Wozniak A; Moerman P; Sciot R; Croce S; Amant F; Vandenberghe P; Cools J; Debiec-Rychter M
    Int J Cancer; 2014 Mar; 134(5):1112-22. PubMed ID: 23959973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas.
    Hrzenjak A
    Orphanet J Rare Dis; 2016 Feb; 11():15. PubMed ID: 26879382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
    Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
    Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma.
    Li X; Anand M; Haimes JD; Manoj N; Berlin AM; Kudlow BA; Nucci MR; Ng TL; Stewart CJ; Lee CH
    Histopathology; 2016 Oct; 69(4):551-9. PubMed ID: 26990025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
    Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Combined BCOR, Cyclin D1, and CD10 in Differentiating Endometrial Stromal Sarcoma From Other Uterine Spindle Cell Lesions.
    Abouelkhair MB; Shakweer MM; Faisal MM; Nasreldin MH; Farid LM
    Appl Immunohistochem Mol Morphol; 2024 Aug; 32(7):326-335. PubMed ID: 38961542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 does not distinguish YWHAE-NUTM2 high-grade endometrial stromal sarcoma from undifferentiated endometrial carcinoma.
    Shah VI; McCluggage WG
    Am J Surg Pathol; 2015 May; 39(5):722-4. PubMed ID: 25871469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.